Healthcare and Pharmaceuticals industry

Global Generic Oncology Sterile Injectable Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Generic oncology sterile injectables are used in treatment of various types of cancers such as ovarian, breast, and lung. These drugs are relatively cheaper than branded counterparts. This is owing presence of same active ingredients, although its inactive contents are different. Cost is a major concern for cancer patients, especially in emerging economies such as India, Brazil, and China. Therefore, governments of such countries are taking efforts to reduce cost of medications and increase its accessibility. For instance, the National Pharmaceutical Pricing Authority (NPPA) of India reduced the prices of a few cancer drugs by 86% in March 2017. Generic oncology sterile injectables have a huge potential in such countries, where patient population is high; however, spending power is relatively low. Furthermore, patent expiry is expected to fuel growth of the generic oncology sterile injectables during the forecast period. Also, the emergence of biosimilars has also impacted growth of generics drugs. For instance, according to the Journal of Generics and Biosimilars Initiative, 2017, biosimilars had a major share in Europe since 2013 and in the U.S. since 2015 and the share of biosimilars is expected to increase significantly in the biologicals market. This is expected to eventually boost growth of the generic oncology sterile injectable market.
Market Dynamics
Generic oncology sterile injectables market is gaining significant traction due to rising prevalence of cancer cases. For instance, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancers were reported in the U.S. Manufacturers are focusing on launching new products to offer low cost treatment to patients. For instance, in November, 2017, Mylan N.V. launched Clofarabine Injection (20 mg/20 mL (1 mg/mL) Single-Dose Vials) following U.S. Food and Drug administration approval in the U.S. market.  Clofarabine is a generic version of Genzyme's Clolar, which is used for treatment of refractory acute lymphoblastic leukemia for patients aged 1 year to 21 years.
Key features of the study:

This report provides in-depth analysis of the generic oncology sterile injectables market and its product type, market size (US$ Million), and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2017 – 2025, considering 2016as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the generic oncology sterile injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
Key companies covered as a part of this study include Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, distribution channel, market expansion, and marketing tactics.
The generic oncology sterile injectables market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for generic oncology sterile injectables market, research and consulting firms, new entrants and financial analysts.
Various strategy matrices used in analyzing the generic oncology sterile injectables market would provide stakeholders vital inputs to make strategic decisions accordingly.

Detailed Segmentation:

Global Generic Oncology Sterile Injectable Market, By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

Global Generic Oncology Sterile Injectable Market, By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

Global Generic Oncology Sterile Injectable Market, By Distribution Channel :

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Generic Oncology Sterile Injectable Market, By Regions :

North America

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

U.S.
Canada


Latin America

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Brazil
Mexico
Rest of Latin America


Europe

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Middle East

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

GCC
Israel
Rest of Middle East


Africa

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

South Africa
Central Africa
North Africa



Company Profiles

Eli Lilly & Company*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Biocon Ltd.
Baxter International Inc.
Hikma Pharmaceuticals PLC
Mylan N.V.
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.


“*” marked represents similar segmentation in other categories in the respective section
Table of Contents
• Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
• Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Disease Indication
? Market Snippet, By Distribution Channel
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
• Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Regulatory Scenario
o Industry Trend
o Merger and Acquisitions
o New Product Approvals/Launch
o Promotion and Marketing Initiatives
• Global Generic Oncology Sterile Injectable Market, By Product Type, 2017 - 2025 (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Chemotherapy
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Alkylating agents
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Antimetabolites
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Plant Alkaloids
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Antitumor Antibiotics
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Others
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Monoclonal Antibodies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Cytokines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Peptide Hormones
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Global Generic Oncology Sterile Injectable Market, By Disease Indication, 2017 - 2025 (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Ovarian Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Breast Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Lung Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Pancreatic Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Global Generic Oncology Sterile Injectable Market, By Distribution Channel, 2017 - 2025 (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Hospital Pharmacies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Retail Pharmacies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
o Online Pharmacies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
• Global Generic Oncology Sterile Injectable Market, By Regions, 2017 - 2025 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2015 - 2025
? Regional Trends
o North America
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• U.S.
• Canada
o Latin America
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
o Europe
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Middle East
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• GCC
• Israel
• Rest of Middle East
o Africa
? Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
• South Africa
• Central Africa
• North Africa
• Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Eli Lilly & Company
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Biocon Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Baxter International Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Hikma Pharmaceuticals PLC
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Mylan N.V.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Sandoz International GmbH
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Teva Pharmaceutical Industries Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Pfizer Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Section
o References
o Research Methodology
o About us and Sales Contact

• *Browse 28 market data tables and 25 figures on "Generic Oncology Sterile Injectable Market" - Global forecast to 2025".
 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.